Print Save or Share

User Reviews for Carbamazepine

Also known as: Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Learn more about Carbamazepine.

Reviews for Carbamazepine to treat Schizoaffective Disorder

No reviews have yet been submitted. Be the first to review this drug.

See also...

Sign In or Register

Forgot password?

Related Carbamazepine Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Positive evidence of risk

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Dibenzazepine anticonvulsants

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

Drug Images

Carbamazepine (chewable) 100 mg

Carbamazepine (chewable) 100 mg

Carbamazepine (chewable) 100 mg

Carbamazepine (chewable) 100 mg

View all 38 images

Get Updates by Email

Email me about carbamazepine systemic:

Related News and Articles

Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain 8 February 2012
Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic...
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 8 February 2012
Feb 8, 2012 - Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc. today announced preliminary top-line results from a Phase III clinical trial of...
Surgery Effective for Tough-to-Treat Epilepsy 7 February 2012
Surgery can significantly improve seizure control and quality of life among people with epilepsy, according to a study stretching over 26 years. "This study...
Alexza Announces Extension of the Adasuve PDUFA Goal Date by Three Months 23 January 2012
Alexza Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) will require additional time to complete its review of the New...
Bipolar Drug May Spur Weight Gain, Thyroid Problems: Review 19 January 2012
A new medical review finds that lithium, a common treatment for bipolar disorder, can lead to weight gain and causes high rates of abnormalities in the thyroid...

Related Questions & Answers

More carbamazepine systemic questions

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

Copyright © 2000-2012 Drugs.com. All rights reserved.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

(web1)